Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study-Reference-Cited by-同舟云学术

Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study

Published:2021-06 Issue: Volume:Volume 14 Page:2925-2933
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Mohan Viswanathan^ORCID,Zargar Abdul,Chawla Manoj,Joshi Ameya,Ayyagari Usha,Sethi Bipin,Gaurav Kumar^ORCID,Patted Usha Rani H,Bhagat Seema Vikas,Mane Amey Ishwara^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference26 articles.

1. Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?

2. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

3. International Diabetes Federation. IDF diabetes atlas 9th edition 2019. Available from: https://www.diabetesatlas.org/en/. Accessed December 31, 2020.

4. Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

5. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation and Quantification of Palmatine from Fibraurea tinctoria Lour: In Vitro Antioxidant Activity and In Silico Antidiabetic Activity Evaluation;Drug Design, Development and Therapy;2024-08

2. A new gas chromatographic method for quantification of Metformin hydrochloride and Vildagliptin in bulk and pharmaceutical dosage form: development and validation;Future Journal of Pharmaceutical Sciences;2024-04-22

3. Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

4. Pharmacokinetics and Food Effect Between a 100‐mg Sustained‐Release Tablet and a 50‐mg Immediate‐Release Tablet of Vildagliptin in Healthy Subjects;Clinical Pharmacology in Drug Development;2023-08-07

5. Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study;Cureus;2023-04-27